Abstract
Research on psychedelics and of their clinical utilization has been evolving separately from placebo research. There are several parallels between this two research fields with possible mutual enrichment.
Substantial role of extrapharmacological variables in psychedelic interventions has implications for next research and for potential regulation of such psychedelic intervention as healthcare service.